{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:00:57Z","timestamp":1778497257237,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"am","delay-in-days":252,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.neurobiolaging.2023.03.005","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T20:57:39Z","timestamp":1678395459000},"page":"33-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Annualized changes in rate of amyloid deposition and neurodegeneration are greater in participants who become amyloid positive than those who remain amyloid negative"],"prefix":"10.1016","volume":"127","author":[{"given":"Ren\u00e9e C.","family":"Groechel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yorghos","family":"Tripodis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Alosco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Qiao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew E.","family":"Budson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil W.","family":"Kowall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Killiany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neurobiolaging.2023.03.005_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jalz.2010.03.006","article-title":"Clinical core of the Alzheimer\u2019s disease neuroimaging initiative: progress and plans","volume":"6","author":"Aisen","year":"2010","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2023.03.005_bib2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jalz.2015.05.005","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative 2 Clinical Core: progress and plans","volume":"11","author":"Aisen","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2023.03.005_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc.: Ser. B Stat. Methodol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2023.03.005_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1750-3639.1991.tb00661.x","article-title":"Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections","volume":"1","author":"Braak","year":"1991","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2023.03.005_bib5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fnagi.2018.00118","article-title":"The physiological roles of amyloid-\u03b2 peptide hint at new ways to treat Alzheimer\u2019s disease","volume":"10","author":"Brothers","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.03.005_bib6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1523\/JNEUROSCI.2111-20.2020","article-title":"Regional tau effects on prospective cognitive change in cognitively normal older adults","volume":"41","author":"Chen","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2023.03.005_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3389\/fnins.2019.00659","article-title":"Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric A\u03b2 and tau species","volume":"13","author":"Chen","year":"2019","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2023.03.005_bib8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest","volume":"31","author":"Desikan","year":"2006","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2023.03.005_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1474-4422(18)30029-2","article-title":"Cognitive and neuroimaging features and brain \u03b2-amyloidosis in individuals at risk of Alzheimer\u2019s disease (INSIGHT-preAD): a longitudinal observational study","volume":"17","author":"Dubois","year":"2018","journal-title":"Lancet Neurol."},{"issue":"19","key":"10.1016\/j.neurobiolaging.2023.03.005_bib10","doi-asserted-by":"crossref","first-page":"e1809","DOI":"10.1212\/WNL.0000000000006469","article-title":"Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults","volume":"91","author":"Farrell","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.03.005_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.biopsych.2011.02.017","article-title":"Cognitively preserved subjects with transitional cerebrospinal fluid ss-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas","volume":"70","author":"Fortea","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.03.005_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.24186","article-title":"Cerebrospinal fluid \u03b2-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease","volume":"76","author":"Fortea","year":"2014","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2023.03.005_bib13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11065-014-9263-8","article-title":"Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan","volume":"24","author":"Fouquet","year":"2014","journal-title":"Neuropsyhol. Rev."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2023.03.005_bib14","first-page":"245","article-title":"Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid \u03b2 positron emission tomography pathology","volume":"10","author":"Gordon","year":"2018","journal-title":"Alzheimer\u2019s Dement.: Diagn. Assess. Dis. Monit."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2023.03.005_bib15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/WNL.0000000000002914","article-title":"The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE","volume":"87","author":"Gottesman","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2023.03.005_bib16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2967\/jnumed.116.176115","article-title":"Predicting regional pattern of longitudinal \u03b2-amyloid accumulation by baseline PET","volume":"58","author":"Guo","year":"2017","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2023.03.005_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13195-021-00834-3","article-title":"Characterization of Alzheimer\u2019s tau biomarker discordance using plasma, CSF, and PET","volume":"13","author":"Guo","year":"2021","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2023.03.005_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13195-020-00665-8","article-title":"Normalization of CSF pTau measurement by A\u03b240 improves its performance as a biomarker of Alzheimer\u2019s disease","volume":"12","author":"Guo","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2023.03.005_bib19","doi-asserted-by":"crossref","first-page":"e1512","DOI":"10.1212\/WNL.0000000000009216","article-title":"Detecting earlier stages of amyloid deposition using PET in cognitively normal elderly adults","volume":"94","author":"Guo","year":"2020","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2023.03.005_bib20","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/alz.12249","article-title":"Distinct effects of beta-amyloid and tau on cortical thickness in cognitively healthy older adults","volume":"17","author":"Harrison","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2023.03.005_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135765","article-title":"Association between CSF A\u03b242 and amyloid negativity in patients with different stage mild cognitive impairment","volume":"754","author":"He","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.neurobiolaging.2023.03.005_bib22","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1073\/pnas.91.8.3270","article-title":"A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease","volume":"91","author":"Hensley","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neurobiolaging.2023.03.005_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuroimage.2015.04.042","article-title":"A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: application to adaptive segmentation of in vivo MRI","volume":"115","author":"Iglesias","year":"2015","journal-title":"Neuroimage"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2023.03.005_bib24","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/alz.12292","article-title":"Application of the ATN classification scheme in a population without dementia: findings from the EPAD cohort","volume":"17","author":"Ingala","year":"2021","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2023.03.005_bib25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2023.03.005_bib26","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"The Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J. Magn. Reson. Imaging"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.03.005_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2023.03.005_bib28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jalz.2015.05.001","article-title":"The Alzheimer\u2019s disease neuroimaging initiative 2 PET core: 2015","volume":"11","author":"Jagust","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2023.03.005_bib29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jamaneurol.2021.5216","article-title":"Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum","volume":"79","author":"Jansen","year":"2022","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2023.03.005_bib30","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2013.09.028","article-title":"Amyloid burden and neural function in people at risk for Alzheimer's disease","volume":"35","author":"Johnson","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"17","key":"10.1016\/j.neurobiolaging.2023.03.005_bib31","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1212\/WNL.0000000000005354","article-title":"Memory decline accompanies subthreshold amyloid accumulation","volume":"90","author":"Landau","year":"2018","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2023.03.005_bib32","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.23908","article-title":"Comparing positron emission tomography imaging and cerebrospinal fluid measurements of \u03b2-amyloid","volume":"74","author":"Landau","year":"2013","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2023.03.005_bib33","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/brain\/awu367","article-title":"Independent information from cerebrospinal fluid amyloid-\u03b2 and florbetapir imaging in Alzheimer\u2019s disease","volume":"138","author":"Mattsson","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2023.03.005_bib34","article-title":"Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau","volume":"31","author":"McCollum","year":"2021","journal-title":"NeuroImage: Clin."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2023.03.005_bib35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jalz.2017.09.013","article-title":"Cortical microstructural changes along the Alzheimer's disease continuum","volume":"14","author":"Montal","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2023.03.005_bib36","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1212\/WNL.0000000000006875","article-title":"Associations between tau, A\u03b2, and cortical thickness with cognition in Alzheimer disease","volume":"92","author":"Ossenkoppele","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2023.03.005_bib37","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41467-017-01150-x","article-title":"Earliest accumulation of \u03b2-amyloid occurs within the default-mode network and concurrently affects brain connectivity","volume":"8","author":"Palmqvist","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2023.03.005_bib38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/joim.12190","article-title":"Mild cognitive impairment: a concept in evolution","volume":"275","author":"Petersen","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2023.03.005_bib39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2023.03.005_bib40","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1038\/s41467-022-34129-4","article-title":"Amyloid-associated increased in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer\u2019s disease","volume":"13","author":"Pichet Binnette","year":"2022","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.neurobiolaging.2023.03.005_bib41","doi-asserted-by":"crossref","first-page":"e1844","DOI":"10.1212\/WNL.0000000000011697","article-title":"Association of digital clock drawing with PET amyloid and tau pathology in normal older adults","volume":"96","author":"Rentz","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2023.03.005_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuroimage.2011.02.076","article-title":"Avoiding asymmetry-induced bias in longitudinal image processing","volume":"57","author":"Reuter","year":"2011","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2023.03.005_bib43","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.neuroimage.2010.07.020","article-title":"Highly accurate inverse consistent registration: a robust approach","volume":"53","author":"Reuter","year":"2010","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2023.03.005_bib44","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.neuroimage.2012.02.084","article-title":"Within-subject template estimation for unbiased longitudinal image analysis","volume":"61","author":"Reuter","year":"2012","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2023.03.005_bib45","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2023.03.005_bib46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2023.03.005_bib47","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","article-title":"Association of factors with elevated amyloid burden in clinically normal older individuals","volume":"77","author":"Sperling","year":"2020","journal-title":"JAMA Neurol."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2023.03.005_bib48","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","article-title":"Cognitive reserve in ageing and Alzheimer's disease","volume":"11","author":"Stern","year":"2012","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.neurobiolaging.2023.03.005_bib49","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jamaneurol.2022.2379","article-title":"Association of elevated amyloid and tau positron emission tomography signal with near-term development of Alzheimer disease symptoms in older adults without cognitive impairment","volume":"79","author":"Strikwerda-Brown","year":"2022","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.03.005_bib50","doi-asserted-by":"crossref","first-page":"fcab008","DOI":"10.1093\/braincomms\/fcab008","article-title":"Detection of \u03b2-amyloid positivity in Alzheimer\u2019s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers","volume":"3","author":"Tosun","year":"2021","journal-title":"Brain Commun."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2023.03.005_bib51","doi-asserted-by":"crossref","first-page":"e662","DOI":"10.1212\/WNL.0000000000011222","article-title":"Association of \u03b2-amyloid level, clinical progression, and longitudinal cognitive change in normal older individuals","volume":"96","author":"van der Kall","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2023.03.005_bib52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.semnuclmed.2016.09.006","article-title":"A\u03b2-amyloid and tau imaging in dementia","volume":"47","author":"Villemagne","year":"2017","journal-title":"Semin. Nucl. Med."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458023000519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458023000519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:44:31Z","timestamp":1759319071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458023000519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":52,"alternative-id":["S0197458023000519"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2023.03.005","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Annualized changes in rate of amyloid deposition and neurodegeneration are greater in participants who become amyloid positive than those who remain amyloid negative","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2023.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}